| Application
|
Percutaneous coronary intervention +
|
| Chemistry
|
Amino acids +
|
| Description
|
C4G1 , YM-337 , Tadocizumab
Fab , source : humanized
|
| Design
|
Antibody +
|
| Name
|
Tadocizumab +
|
| Sequence
|
Tadocizumab fab fragment : DIQMTQTPSTLSAS … Tadocizumab fab fragment : DIQMTQTPSTLSASVGDRVTISCRASQDINNYLNWYQQKPGKAPKLLIYYTSTLHSGVPSRFSGSGSGTDYTLTISSLQPDDFATYFCQQGNTLPWTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECxxxxxTadocizumab fab fragment : QVQLVQSGAEVKKPGSSVKVSCKASGYAFTNYLIEWVRQAPGQGLEWIGVIYPGSGGTNYNEKFKGRVTLTVDESTNTAYMELSSLRSEDTAVYFCARRDGNYGWFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH
|
| Categories |
Sequence +
|
| Modification dateThis property is a special property in this wiki.
|
2 March 2015 02:21:18 +
|
